Prevalence of Immunosuppression Among US Adults
- PMID: 38358771
- PMCID: PMC10870224
- DOI: 10.1001/jama.2023.28019
Prevalence of Immunosuppression Among US Adults
Plain language summary
This analysis presents population prevalence estimates of immunosuppression among US adults using data from the 2021 National Health Interview Survey.
Conflict of interest statement
References
-
- Link-Gelles R, Weber ZA, Reese SE, et al. . Estimates of bivalent mRNA vaccine durability in preventing COVID-19–associated hospitalization and critical illness among adults with and without immunocompromising conditions—VISION Network, September 2022-April 2023. MMWR Morb Mortal Wkly Rep. 2023;72(21):579-588. doi:10.15585/mmwr.mm7221a3 - DOI - PMC - PubMed
-
- Patel P, Twentyman E, Koumans E, et al. . Information for persons who are immunocompromised regarding prevention and treatment of SARS-CoV-2 infection in the context of currently circulating Omicron sublineages—United States, January 2023. MMWR Morb Mortal Wkly Rep. 2023;72(5):128-131. doi:10.15585/mmwr.mm7205e3 - DOI - PMC - PubMed
-
- US Centers for Disease Control and Prevention . National Health Interview Survey. Accessed January 14, 2023. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHI...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
